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Abstract
Mycobacterium tuberculosis requires the enzyme isocitrate lyase (ICL) for growth and virulence in vivo. The demonstration
that M. tuberculosis also requires ICL for survival during nutrient starvation and has a role during steady state growth in a
glycerol limited chemostat indicates a function for this enzyme which extends beyond fat metabolism. As isocitrate lyase is
a potential drug target elucidating the role of this enzyme is of importance; however, the role of isocitrate lyase has never
been investigated at the level of in vivo fluxes. Here we show that deletion of one of the two icl genes impairs the
replication of Mycobacterium bovis BCG at slow growth rate in a carbon limited chemostat. In order to further understand
the role of isocitrate lyase in the central metabolism of mycobacteria the effect of growth rate on the in vivo fluxes was
studied for the first time using 13C-metabolic flux analysis (MFA). Tracer experiments were performed with steady state
chemostat cultures of BCG or M. tuberculosis supplied with 13C labeled glycerol or sodium bicarbonate. Through
measurements of the 13C isotopomer labeling patterns in protein-derived amino acids and enzymatic activity assays we
have identified the activity of a novel pathway for pyruvate dissimilation. We named this the GAS pathway because it
utilizes the Glyoxylate shunt and Anapleurotic reactions for oxidation of pyruvate, and Succinyl CoA synthetase for the
generation of succinyl CoA combined with a very low flux through the succinate – oxaloacetate segment of the tricarboxylic
acid cycle. We confirm that M. tuberculosis can fix carbon from CO2 into biomass. As the human host is abundant in CO2 this
finding requires further investigation in vivo as CO2 fixation may provide a point of vulnerability that could be targeted with
novel drugs. This study also provides a platform for further studies into the metabolism of M. tuberculosis using 13C-MFA.
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Introduction
Initial infection with Mycobacterium tuberculosis is either
asymptomatic or leads to the development of acute disease
(primary tuberculosis). In both cases, infection (including
recovery in the absence of treatment) is generally followed by
a period of latency which may last for months, years, decades or
a lifetime. Reactivated tuberculosis (post-primary) can occur at
any time and is a major source of transmission. Unlike many
pathogens M. tuberculosis does not rely on the production of
specific toxins to cause disease. Rather the ability to adapt and
survive within the changing and adverse environment provided
by the human host during the course of an infection seems to be
the secret to the success of M. tuberculosis. It is becoming
apparent that key to this adaptation is the metabolic repro-
gramming of M. tuberculosis during both the acute and chronic
phase of tuberculosis (TB) disease and therefore a more
complete understanding of mycobacterial metabolism remains
a major goal of TB research.
Our previous studies have investigated the influence of growth
rate on metabolism in M. tuberculosis [1,2]. We found significant
differences in macromolecular composition between fast and slow-
growing cells [1] and demonstrated that the transcriptional
response to slow growth in vitro has many similarities to the
transcriptional response characteristic of the adaptation of M.
tuberculosis to the macrophage environment [3]. Growth rate
modulation is therefore likely to be a significant component of the
adaptation of M. tuberculosis to the host environment. Yet, the shift
to slow growth is much more than a general slowing down of
cellular processes. Global mutagenesis analysis demonstrated that
growth rate control in M. tuberculosis is in fact a carefully
orchestrated process which requires a distinct set of genes
encoding several virulence determinants, gene regulators, and
metabolic enzymes [4]. However, the precise metabolic changes
that underlie the shift to slow growth both in vitro and in vivo remain
unclear.
We previously investigated the metabolic response of slow
growing glycerol-limited M. tuberculosis in silico using flux balance
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analysis (FBA) of our genome-scale reconstruction of TB
metabolism [2]. The most significant result of this study was a
predicted increase in flux through the isocitrate lyase reaction
during slow growth. This hypothesis was tested experimentally
using our chemostat-based experimental system of mycobacterial
growth [1]. By directly measuring the activity of isocitrate lyase, in
fast and slow growing BCG cells from a chemostat we
demonstrated that isocitrate lyase activity was, in accordance with
predictions, induced during slow growth [1].
Isocitrate lyase (ICL) has been shown to have an essential role in
the survival and persistence of M. tuberculosis in both macrophages
and mice [5,6] and is also essential for the persistence of other
intracellular pathogens [7,8]. As this enzyme is apparently absent
from human cells, ICL has been intensively investigated as an
attractive target for drug development.
The glyoxylate shunt is an anaplerotic pathway important for
the metabolism of fatty acids which is mediated by the enzyme
ICL along with malate synthase. The essentiality of ICL in the
survival and persistence of M. tuberculosis has therefore been
generally interpreted to be due to this enzyme’s role in the
glyoxylate shunt and reflect a metabolic shift in the principal
carbon source from carbohydrates to fat in the host. However, the
ICL’s of M. tuberculosis also function as methylisocitrate lyases in
the methyl citrate cycle where they are involved in the metabolism
of propionyl-CoA [9]. More recently ICL has been shown to be
essential for intracellular ATP level reduction in a nutrient
starvation model of persistence [10] and the glyoxylate shunt has
been shown to operate concurrently with an oxidative (tricarbox-
ylic acid) TCA cycle which is completed by an anaerobic a-
ketoglutarate ferredoxin oxidoreductase (KOR) [11]. Our in vitro
enzyme activity data demonstrates a role for ICL during slow
growth rate on glycerol [2], a substrate that would be expected to
be catabolised via glycolysis and the TCA cycle and provided a
first clue that the glyoxylate shunt in M. tuberculosis operates under
more general conditions.
However, FBA cannot provide unique solutions for intracellular
fluxes because of the existence of multiple parallel pathways; so the
method could not identify the metabolic pathways utilized by M.
tuberculosis during slow growth. A more direct means of establishing
the intracellular fluxes is through 13C metabolic flux analysis (13C-
MFA). This powerful technique has been successfully applied to
identify functional flux states in various microbes [12,13] and has
enormous potential for studying the metabolism of M. tuberculosis.
The method utilizes the fact that amino acids are constructed from
metabolic precursors in central metabolism. Growth of a cell with
13C-labeled substrate therefore leads to a pattern of 13C
incorporation in the proteinogenic amino acids that is determined
by the intracellular fluxes to these compounds. Computational
tools may then be used to find the values of the intracellular fluxes
that are consistent with the pattern of amino acid labeling, as
determined by NMR or mass spectrometry.
In this study we further examine the hypothesis that ICL plays a
role in dissimilation of carbohydrates in M. tuberculosis at slow
growth rates using mutational, enzymatic and macromolecular
analysis. We demonstrate that ICL is actually essential in slowly
growing Mycobacterium bovis BCG in a glycerol-limited chemostat.
In addition we use 13C-MFA to determine the metabolic
phenotype of M. bovis BCG at fast and slow growth rates and M.
tuberculosis H37Rv at slow growth rate, in order to provide a
system-level understanding of the metabolism of slowly growing
mycobacteria and particularly the role of ICL. This approach
provides a novel insight into the M. tuberculosis metabolism that
may have implications for how the tubercle bacillus survives in vivo.
Results
Deletion of icl1 from M. bovis BCG
To further explore the role of ICL during slow growth, the icl1
gene was deleted from BCG to generate BCGDicl1 and this was
confirmed by Southern blot (Figure S1). Enzyme activity of the
resulting mutant (1.32 nmol min21 mg protein21) was less than
one tenth that of the wild type value (21.20 nmol min21 mg
protein21). The residual activity demonstrates that another gene
encodes an active ICL in M. bovis BCG. Two ICL genes have been
identified in M. tuberculosis H37Rv (icl1 and icl2) but only one (icl1)
encodes a functional enzyme in this strain [14]. In M. tuberculosis
CSU93 [14], M. bovis [15] and M. avium both genes encode active
enzymes. The arrangement of the isocitrate lyase genes in the M.
bovis BCG genome sequence suggests that both enzymes are also
functional in this strain and the data presented here confirms this.
Growth of Dicl1 in continuous culture in a chemostat
The phenotype of the Dicl1 mutant strain was characterized at
two specific growth rates in the chemostat: mS=0.03 h21
(td = 23 h) and mF=0.01 h21 (td = 69 h). The physiological [1]
and transcriptomic [3] profile and also the genetic requirements
[4] of mycobacterial cells at these growth rates have been
described previously. The loss of the icl1 gene did not impair the
ability of the mutant to adapt to growth in the bioreactor, as
growth of the mutant strain was indistinguishable from the wild
type during the batch phase (Figure 1). However, the wild type and
mutant strain behaved very differently after media flow from the
feed reservoir into the bioreactor was initiated in order to establish
carbon-limited continuous culture conditions. At a dilution rate of
0.01 h21 (corresponding to a doubling time of 69 h), wild type
BCG reached a steady state after approximately six volume
changes (day 40) after which little variation was observed in the
CO2 and biomass production rates, indicating that steady state
(continuous culture) conditions had been attained (Figure 2). Cells
were harvested for analysis at day 42. In contrast, Dicl1 mutant
strain appeared unable to establish a steady-state at this growth
rate. Instead, the biomass and CO2 production of Dicl1 mutant
culture declined continuously from day 16 until day 59 when the
Author Summary
The role of the enzyme isocitrate lyase (ICL) in the
metabolism of Mycobacterium tuberculosis has been
intensively studied since the demonstration that both of
the isocitrate lyase genes encoded by this pathogen, icl1
and icl2 (although some strains only have icl1) are essential
for the survival of this pathogen in the host. This finding
has been generally interpreted as being due to a shift to
the consumption of fats in the host. We previously
demonstrated increased ICL activity when the vaccine
strain of M. tuberculosis (BCG) was growing slowly on
carbohydrates, suggesting a more extended role for ICL
than just fat metabolism. Here we show that the gene icl1
is actually essential for slow growth on glycerol. By feeding
BCG and M. tuberculosis cells isotopically labeled carbon
sources and using a combination of experimental and
computational analysis we identified a novel metabolic
route for carbohydrate metabolism in which ICL is a key
enzyme. We also demonstrated that M. tuberculosis is able
to acquire biomass carbon from CO2. As CO2 is abundant
in the human host, inhibition of CO2 fixation could be
exploited in the development of novel drug treatments
against tuberculosis.
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strain was completely washed out of the chemostat and the
experiment was terminated (Figure 2). Consumption of glycerol
also differed between the two strains during the course of the
experiment (Figure 2). The Dicl1 mutant consumed glycerol much
more slowly than the wild type BCG. Growth of the Dicl1 mutant
was similar to the wild type strain up to the point at which
glycerol became limited, which occurred at day 16 for Dicl1 and
at day 10 for the wild type strain (Figure 2). After this point the
growth of the wild type adjusted to the rate of nutrient supplied
by the chemostat to reach steady state whereas the Dicl1 mutant
started to flush out from the bioreactor vessel. These results
indicated that loss of icl1 significantly changed the growth
properties of M. bovis BCG even when growing with glycerol as
the principal carbon source.
In contrast, the behavior of the wild type and Dicl1 mutant was
similar in the chemostat at a higher dilution rate of 0.03 h21
(corresponding to a doubling time of 23 h) (Figure 3) in that both
wild type and mutant attained a steady state after 22 days of
growth (five volume changes). There were however significant
physiological differences between wildtype and mutant strains
(Table 1). A significant decrease in the specific glycerol uptake
rate, increased CO2 production and an increased biomass yield
was observed for the Dicl1 mutant compared with the wild type.
Interestingly the Tween 80 consumption rates did not differ
significantly between the wild type and mutant strains (Table 1).
Macromolecular analysis demonstrated that whereas the relative
fraction of lipid was similar for wild type icl1 mutant strains
(Table 1) the carbohydrate content was markedly decreased in the
icl1 mutant and this was balanced by an increase in protein
content.
Enzyme activities
We have previously demonstrated that the in vitro activities of
ICL were two-fold higher in slow (td = 69 h) growing chemostat
cultures than in the more rapidly (td = 23 h) growing cultures [2].
In order to further explore the unexpected role of ICL at slow
growth we measured the in vitro activities of the competing enzyme,
isocitrate dehydrogenase (IDH), and also enzymes involved in
downstream anaplerotic reactions (Table 2) in the wild-type strain.
We also measured the activity of glycine dehydrogenase (GDH) as
this enzyme was shown to act in concert with ICL in Wayne’s
model of non-replicating persistence [16]. As these enzymes play
important roles in controlling the distribution of metabolic flux in
the cell this could provide information about the metabolic wiring
during slow growth rate. Consistent with elevation of the
glyoxylate pathway, in vitro activity of IDH was 50% lower at
the slow as compared with the fast growth rate (Table 2). The
pattern of the anaplerotic phosphoenolpyruvate carboxykinase
(PCK) enzyme activity paralleled that of ICL and higher activities
were observed at slow growth rate as compared with fast growth
rate. The in vitro activity of the competing anaplerotic enzyme,
pyruvate carboxylase (PCA) was however below the detection level
of the assay at both growth rates indicating that this enzyme is
either inactive in the growth conditions tested or that the assay
conditions were not optimum. Very low levels of malic enzyme
(MEZ) were also detected at both growth rates. This is in
Figure 1. Batch cultivation of M. bovis BCG and nicl1 in a bioreactor. A 10% late log phase culture of M. bovis BCG (black line) or nicl1 (red
line) was inoculated into the bioreactor and optical density at 600 nm was monitored for 4 d prior to switching to chemostat mode. Average values
and standard deviations are shown from two independent experiments.
doi:10.1371/journal.ppat.1002091.g001
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accordance with previous observations [17]. GDH activity was
detected in almost equal amounts at both growth rates.
13C MFA of M. bovis BCG
In order to complement the enzyme activity data and further
explore the metabolic phenotype of slowly growing mycobacterial
cells we performed metabolic flux analysis (MFA) using
[13C3]glycerol. The labeling experiments with M. bovis BCG were
carried out at both fast (td = 23 h) and slow (td = 69 h) growth
rates. The physiological characteristics of cells at these growth
rates are summarized in Table 1. Our initial data demonstrated
that, in addition to glycerol, Tween 80 was also utilized by BCG as
Figure 2. Continuous culture of M. bovis BCG andnicl1 at a dilution rate of 0.01 h21 (td = 69.3 h). A 10% late log phase culture of M. bovis
BCG (A) and nicl1 (B) was inoculated into the bioreactor. The cultures were operated as batch until day 4. Continuous culture was then started at a
dilution rate of 0.01 h21 Samples were removed and assayed for biomass (red line). CO2 production in the waste gas was measured using a dual
tandem sensor gas analyser (green line) and filtered supernatants were assayed for glycerol (blue line). The results are representative of two
experiments.
doi:10.1371/journal.ppat.1002091.g002
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Figure 3. Continuous culture ofM. bovis BCG andnicl1 at a dilution rate of 0.03 h21 (td =23.1 h). A 10% late log phase culture of M. bovis
BCG (black line) or nicl1 (red line) was inoculated into the bioreactor. The cultures were operated as batch until day 4. Continuous culture was then
started at a dilution rate of 0.03 h21. Samples were removed and assayed for biomass (circles). CO2 production in the waste gas was measured using
a dual tandem sensor gas analyser (squares). The results are representative of two experiments.
doi:10.1371/journal.ppat.1002091.g003
Table 1. Steady state characteristics of wild type and nicl strains of M.bovis BCG (BCG) and wild type M. tuberculosis (MTB) grown
in a glycerol-limited chemostat.
Organism BCG MTB
Strain Wild type nicl Wild type
Dilution rate (h21) 0.01 0.03 0.03 0.01
Biomass (g dry weight l21) 1.40 0.70 0.30 1.28
CFU (6106 ml21) 164 51.0 26.85 144
Specific glycerol consumption rate (mmol g biomass21 h21) 0.39 0.74 0.57 0.39
Specific Tween 80 consumption rate (mmol g biomass21 h21) 0.002 0.09 0.07 0.003
Specific CO2 production rate (mmol g biomass
21 h21) 0.57 0.45 0.69 0.23
Protein content (g l21) 22.91* 21.40* 32.74 -
Carbohydrate content (g l21) 29.20* 21.91* 14.37 -
Lipid content (g l21) 33.90* 44.82* 48.14 -
Yield (g bacteria g glycerol21) 0.30 0.46 0.56 0.22
Values are the averages from duplicate chemostat cultures and three independent measurements. * Data from Beste et al. (2005).
doi:10.1371/journal.ppat.1002091.t001
13C Metabolic Flux Analysis of Mycobacteria
PLoS Pathogens | www.plospathogens.org 5 July 2011 | Volume 7 | Issue 7 | e1002091
a carbon source during the chemostat experiments. We therefore
developed and utilized an assay to measure Tween 80 uptake
(Methods) in the chemostat, and Tween 80 was also included as a
carbon source in the metabolic flux analysis. Perhaps surprisingly,
significantly less of the available Tween 80 was consumed during
slow growth (16%) than at the faster growth rate (43%).
Steady state chemostat cultures were switched to medium
containing 20% [13C3]glycerol and samples were removed for
analysis every volume change for a minimum of five volume
changes. Labeling of proteinogenic amino acids was measured
using gas chromatography coupled to mass spectrometry (GC-
MS). The labeling pattern of most of the fragments changed very
little between the third and fourth volume change indicating that
the culture had reached an isotopic steady state (Table S1). After
correction for the naturally occurring isotopes of atoms other than
carbon, experimental GC-MS data was compared to data
simulated from flux distributions using the 13CFLUX software
package (Table S3; Table S4) [18].
For flux calculations we constructed an isotopomer model
composed of reactions extracted from our GSMN-TB model [2]
and included the reactions of glycolysis, the pentose phosphate
pathway, the TCA cycle and anaplerosis. This isotopomer model
is applicable to both M. bovis BCG and M. tuberculosis as current
knowledge indicates that these pathways are identical in these two
species. The model included fully formulated amino acid
biosynthesis pathways and reactions for output of metabolic
precursors to biomass, allowing estimate of the fluxes to biomass
from each precursor, which are shown as output fluxes in Figure 4
and Table S2. This was a relatively large network for analysis and
therefore we simplified this initial network to the point where it
could be solvable using the GC-MS data. M. tuberculosis and M.
bovis BCG are peculiar in that two distinct and unconventional
TCA cycles are utilized [11,19]. Lacking the traditional TCA
ketoglutarate dehydrogenase (KGD) both M. tuberculosis and M.
bovis BCG express an anaerobic a-ketoglutarate ferredoxin
oxidoreductase (KOR) normally associated with the reductive
TCA cycle and this is thought to complete the oxidative TCA
cycle [11]. In addition a novel TCA cycle which uses an
alternative pathway from a-ketoglutarate to succinate via succinic
semialdehyde has also been proposed in M. tuberculosis [19]. The
existence of this pathway is now called into question due to the re-
characterisation of the proposed a-ketoglutarate decarboxylase
(KGD) as a 2-hydroxy-3-oxoadipate synthase [20]. However, these
pathways cannot be distinguished by 13C-MFA as the carbon flow
from a-ketoglutarate to succinate is the same irrespective of which
route is taken. Consequently both routes are combined and
lumped into one flux model. Simplifications were also introduced
where the accuracy of flux estimates was predicted to be poor. For
example based on available measurements it was also not possible
to discriminate between the MEZ and PCA reactions with high
confidence so the summed flux is shown between pyruvate and
malate/oxaloacetate. The refined network is illustrated in Figure 4
and the component steps defined in Table S2.
In addition, in order to directly compare the fast (D=0.03 h21,
td = 23 h) and slow (D= 0.01 h
21, td = 69 h) growth rates and also
to incorporate information from the enzymatic data the final
isotopomer model consists of two sub-models, representing fast
and slow growth rates. Both sub-models are structurally identical
and are coupled via inequality constraints to reflect the tendencies
of the measured in vitro enzyme activities (Table 2).
0§iclF{iclS
0§icdhS{icdhF
0§pckF{pckS
This allowed the parameter estimation process to fit simulta-
neously all of the measured data for both growth rates without
hard coding enzyme activity measurements.
All fluxes were normalized relative to the rate of glycerol uptake
which was considered to be 100. A unique best fit was obtained for
the fast growth rate BCG (Figure 5) whereas two significantly
different, but equally likely solutions (A and B) were obtained for
the slow growth rate (Figure 6 and 7; Table S5). For the slow
growth rate therefore it can be concluded that the flux values
cannot be determined unambiguously from the available labeling
data. This is a relatively common outcome in 13C-MFA. The
major differences in these two flux solutions are in the operation of
the gluconeogenesis, the pentose phosphate pathway and the
output of acetyl CoA. However, whilst there are differences
between the two slow growth rate solutions they share a common
metabolic route for pyruvate dissimilation via the TCA cycle,
glyoxylate shunt and anaplerotic reactions and we therefore focus
our conclusions on the operation of these pathways.
According to the weak constraints applied to the model (see
above) ICL flux was higher at the slow growth rate (8.76–9.04%)
than at the fast growth rate (5.49%) for both slow growth rate
solutions. In addition, at either the slow or fast growth rate use of
the glyoxylate shunt was coupled with an unexpectedly low flux
(0–1.55% at slow growth rate and 0.02% at fast growth rate)
through the later part of the TCA (from succinate to malate/
oxolacetate) with the malate/oxaloacetate pool being replenished
primarily using carbon fixing anaplerotic reactions. Another
interesting feature of the BCG flux solutions obtained for both
fast and slow growth rates was a negative flux (going in the
reductive direction) through the a-ketoglutarate ferredoxin
oxidoreductase (KOR) reaction. Approximately 11% of the
oxalocetate originated from the anaplerotic PCK at slow growth
rate, whereas at fast growth rate there was only a 1.2% anaplerotic
flux through PCK with an additional 3.47% flux to malate/
oxaloacetate through the reactions catalysed by either PCA or
MEZ. Both slow growth rate solutions show a negative flux from
succinate to succinyl CoA via succinyl-CoA synthetase (SCS)
whereas at the fast growth rate there is negligible flux to succinyl
CoA. Succinyl CoA is a precursor of methyl branched lipids,
which are a major component of biomass, as well as being used for
synthesis of diaminopepimelate, sulpholipids and heme. The
Table 2. In vitro enzyme activities in crude cell extracts of
glycerol limited chemostat cultures of Mycobacterium bovis
BCG.
Dilution rate (h21) 0.01 0.03
Doubling time (h) 69.3 23.1
Enzyme activities (nmol mg protein21 min21)
Isocitrate lyase * 42.6762.68 21.2060.69
Isocitrate dehydrogenase 31.6615.9 66.8611.9
PEP carboxykinase 52.4263.88 36.7161.78
Pyruvate carboxylase ,1 ,1
Malic enzyme 3.2060.60 3.3660.39
Glycine dehydrogenase 7.1360.227 6.0960.18
Results represent the average values with standard deviations from duplicate
independent chemostat runs. * Data from Beste et al. (2007).
doi:10.1371/journal.ppat.1002091.t002
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Figure 4. Metabolic network of the central metabolism of Mycobacterium bovis BCG. Glycolysis/gluconeogenesis (green), oxidative pentose
phosphate pathway (orange), tricarboxylic acid cycle (TCA, pink), anaplerotic reactions (blue), and biosynthesis (grey). Standard abbreviations are
used for the amino acids. Metabolite abbreviations: ACCOA, acetyl-CoA; ACE, acetate; CHO, chorismate; E4P, D-erythrose 4-phosphate; F6P, D-fructose
6-phosphate; FBP, D-fructose 1,6-bisphosphate; FUM, fumarate; G6P, D-glucose 6-phosphate; GA3P, glyceraldehyde 3-phosphate; GLX, glyoxylate;
GLYC, glycerol; ICIT, isocitrate/citrate; KIV, 2-oxoisovalerate; MALOAA, L-malate-oxaloacetate; OXG, 2-oxoglutarate; R5P,a- D -ribose 5-phosphate/L
-ribulose 5-phosphate/L-xylulose 5-phosphate; PEP, phosphoenolpyruvate; PGA, 2-phospho- D -glycerate/3-phospho- D-glycerate; PYR, pyruvate; S7P,
sedoheptulose 7-phosphate; SUC, succinate; SUCCOA, succinyl-CoA. Enzyme abbreviations: CS: citrate synthase; ENO: enolase; FBA: fructose-
bisphosphate adolase; FBP: fructose-bisphosphatase; FUM:fumurase; GAPA: glyceraldehyde 3-phosphate dehydrogenase; GND: 6-phosphogluconate
dehydrogenase; ICL: isocitrate lyase; ICDH: isocitrate dehydrogenase NADP-dependent; KOR/KGD: a-ketoglutarate ferredoxin oxidoreductase/a-
ketoglutarate decarboxylase;MEZ/PCA: malic enzyme/pyruvate carboxylase: MDH: malate dehydrogenase; MS: malate synthase; PCK: phosphoenol-
pyruvate carboxykinase; PDH: pyruvate dehydrogenase; PGI: glucose phosphate isomerase; PYK: pyruvate kinase;SDH: succinate dehydrogenase; SCS:
Succinyl CoA synthetase; TAL: transaldolase; TKT1/2: transketolase. Explicit names are also given in Table S6. The picture was generated with Omix, an
editor for biochemical networks and visualization tool [http://www.13cflux.net/omix].
doi:10.1371/journal.ppat.1002091.g004
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Figure 5. In vivo flux distribution of M. bovis BCG in glycerol limited continuous culture at fast growth rate (td = 23 h). Flux values were
normalized to the specific glycerol uptake rate which was arbitrarily given the value of 100. Arrows are pointing in the net flux direction and the
width of each line is proportional to the underlying flux value. Numerical values of estimated fluxes (Table S5) are indicated on each flux arrow. The
abbreviations are as in Figure 4.
doi:10.1371/journal.ppat.1002091.g005
13C Metabolic Flux Analysis of Mycobacteria
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increased flux to succinyl CoA may therefore reflect an increased
requirement for some or all of these metabolites at slow growth
rate. In contrast to the increased succinate/succinyl CoA output
flux at slow growth rate, there was a dramatic increase in the
output flux of acetyl CoA at the fast growth rate and this was also
present in one of the two solutions for slow BCG cells.
Figure 6. Metabolic flux map corresponding to solution A forM. bovis BCG in glycerol limited continuous culture at slow growth rate
(td = 69 h). Flux values were normalized to the specific glycerol uptake rate which was arbitrarily given the value of 100. Mass spectral data of
proteinogenic amino acids from steady state chemostat cultures grown on a mixture of 20% [U-13C] glycerol and 80% unlabeled glycerol and the
physiological data of Table 1 were used to generate the two alternative flux estimations. Arrows are pointing in the net flux direction and the width
of each line is proportional to the underlying flux value. Numerical values of estimated fluxes (Table S5) are indicated on each flux arrow. The
abbreviations are as in Figure 4.
doi:10.1371/journal.ppat.1002091.g006
13C Metabolic Flux Analysis of Mycobacteria
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13C MFA of M. tuberculosis
In order to confirm that the observed metabolic pathway for
pyruvate dissimilation in slowly growing BCG was also occurring
in M. tuberculosis we performed steady state chemostat cultivations
of the tubercule bacillus at a dilution rate of 0.01 h21 (td = 69.3 h).
The steady state glycerol and Tween 80 consumption rates were
very similar to those of BCG (Table 1). M. tuberculosis exhibited a
lower CO2 production rate (0.23 mmol g biomass
21 h21)
compared to BCG (0.57 mmol g biomass21 h21).
The metabolic fluxes for slowly growing M. tuberculosis were
calculated from GC-MS data obtained from steady state
[13C]glycerol labeling experiments by applying methodology
similar to that used for BCG (Table S4). Again the flux values
could not be determined unambiguously from the available
Figure 7. Metabolic flux map B for M. bovis BCG in glycerol limited continuous culture at slow growth rate (td =69 h). Flux values were
normalized to the specific glycerol uptake rate which was arbitrarily given the value of 100. Mass spectral data of proteinogenic amino acids from
steady state chemostat cultures grown on a mixture of 20% [U-13C] glycerol and 80% unlabeled glycerol and the physiological data of Table 1 were
used to generate the two alternative flux estimations. Arrows are pointing in the net flux direction and the width of each line is proportional to the
underlying flux value. Numerical values of estimated fluxes (Table S5) are indicated on each flux arrow. The abbreviations are as in Figure 4.
doi:10.1371/journal.ppat.1002091.g007
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labeling data and two best-fit solutions were obtained (Figure 8
and 9; Table S5). As found with BCG, the major differences
between the two solutions were in the flux through gluconeogen-
esis, the pentose phosphate pathway and the output of acetyl CoA.
Although the present data do not allow a unique flux solution,
these data show that M. tuberculosis and BCG are operating the
same route for pyruvate dissimilation which is characterized by
flux through the glyoxylate shunt, synthesis of oxaloacetate
primarily by an anaplerotic reaction from either phosphoenolpyr-
uvate or pyruvate rather than via the TCA cycle and succinyl CoA
synthetase for the generation of succinyl CoA . We have named
this the GAS pathway (Figure 10) because of the usage of the
Figure 8. Metabolic flux map corresponding to solution A for M. tuberculosis in glycerol limited continuous culture at slow growth
rate (td =69 h). Flux values were normalized to the specific glycerol uptake rate which was arbitrarily given the value of 100. Both of the presented
flux maps are able to describe the 13C labeling profiles of proteinogenic amino acids and measured extracellular flux values from steady state cultures
of M. tuberculosis at slow growth rate. Arrows are pointing in the net flux direction and the width of each line is proportional to the underlying flux
value. Numerical values of estimated fluxes (Table S5) are indicated on each flux arrow. The abbreviations are as in Figure 4.
doi:10.1371/journal.ppat.1002091.g008
13C Metabolic Flux Analysis of Mycobacteria
PLoS Pathogens | www.plospathogens.org 11 July 2011 | Volume 7 | Issue 7 | e1002091
Glyoxylate shunt, Anaplerotic fixation of carbon from CO2 and
Succinyl CoA synthetase for the generation of succinyl CoA.
An interesting feature of the GAS pathway is the synthesis of
oxaloacetate by anaplerotic reactions. These anaplerotic reactions
involve assimilation of a carbon atom from CO2; so, to
independently confirm this aspect of the flux solution we
performed labeling experiments with [13C]sodium bicarbonate.
Biomass samples were taken from steady state chemostat cultures
of Mycobacterium tuberculosis growing at either fast or slow growth
rate in media containing unlabeled glycerol and [13C]sodium
bicarbonate. Because the rate of labeled and unlabeled CO2
uptake could not be accurately quantified (since bicarbonate is
Figure 9. Metabolic flux map B for M. tuberculosis in glycerol limited continuous culture at slow growth rate (td = 69 h). Flux values
were normalized to the specific glycerol uptake rate which was arbitrarily given the value of 100. Both of the presented flux maps are able to describe
the 13C labeling profiles of proteinogenic amino acids and measured extracellular flux values from steady state cultures of M. tuberculosis at slow
growth rate. Arrows are pointing in the net flux direction and the width of each line is proportional to the underlying flux value. Numerical values of
estimated fluxes (Table S5) are indicated on each flux arrow. The abbreviations are as in Figure 4.
doi:10.1371/journal.ppat.1002091.g009
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labile), it was not possible to perform full 13C-MFA analysis of
these experiments. However, GC-MS analysis of the proteinogenic
amino acids clearly demonstrated incorporation of the CO2-
derived 13C into several amino acids including those derived from
oxaloacetate, such as lysine (Table S4) at both the fast and slow
growth rates, which is consistent with CO2 being fixed into
biomass. Additionally, there were distinct differences in the degree
of labeling of amino acids between fast and slow-growing cells. For
instance, 22% of lysine is labeled with 13C at slow growth rate but
16% at fast growth rate. These ratios were reversed for methionine
which is 16% labeled at fast growth rate but less than 5% at slow
growth rate. These differences indicate growth rate-dependent
shifts in the relative flux through anaplerotic carboxylating
reactions.
Figure 10. The GAS pathway. Schematic of the GAS pathway which is characterised by flux through the glyoxylate shunt and anaplerotic
reactions for oxidation of pyruvate and succinyl CoA synthetase for the generation of succinyl CoA. The substrate abbreviations are as in Figure 4.
doi:10.1371/journal.ppat.1002091.g010
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Discussion
The demonstration that ICL was essential for the multiplication
of M. tuberculosis in macrophages and mice [5,6] was interpreted as
further evidence that fats are the major carbon source for this
pathogen in the human host. Subsequent studies and the data
presented here demonstrate that the function of ICL extends
beyond lipid metabolism and that this enzyme has a role in the
central metabolism of mycobacteria [2,10,11]. Our results show
that ICL’s were utilized even when glycerol was the major carbon
source and that disruption of just one of the two functional icl
genes impairs the viability of M. bovis BCG growing slowly in a
carbon limited chemostat. Although the strain behaved like the
parental strain at the faster growth rate (corresponding to a
doubling time of 23 h), disruption of the icl1 gene resulted in a loss
of viability at the slower growth rate (corresponding to a doubling
time of 69 h). This finding echoes the previous demonstration that
persistence of the icl1 mutant was attenuated in mice [5] and
suggests that slow growth in the chemostat may simulate some
aspects of in vivo growth. It also demonstrates the value of the
chemostat for identifying growth-rate dependent phenotypes.
The essential requirement of icl1 for adaptation of BCG to slow
growth under glycerol limiting conditions was not due to an
increased consumption of the hydrolysis products of the detergent
Tween 80 which is added to mycobacterial cultures to minimize
clumping. Although some Tween 80 was metabolized by BCG
during carbon limited growth in a chemostat, the Tween 80
consumption rate was significantly lower at slow growth rate than
at the faster growth rate. In addition, the Tween 80 consumption
rate did not differ significantly between the wild type and
BCGDicl1. Whilst deletion of icl1did not reduce viability of M.
bovis BCG at the faster growth rate in the chemostat, our findings
indicate that the icl1 mutant had altered biomass yields and
macromolecular composition, indicating that the icl1 gene is also
playing a non-essential role in the physiology of BCG at the higher
growth rate. Although it is unclear why the removal of icl1 results
in an increased yield on glycerol it is consistent with similar
findings for Escherichia coli where it was demonstrated that a
functional icl gene was associated with a growth disadvantage in
competition experiments in the chemostat [21]. The reduction in
the carbohydrate content of the mutant cells indicate that the
glyoxylate shunt may be involved in providing precursors for
biosynthesis of non-essential carbohydrates. The metabolic cost of
producing these carbohydrates is a possible explanation of the
increased yield of the ICL mutant.
Using enzymatic methods and 13C-MFA we have identified a
new route for pyruvate dissimilation which occurs in both BCG
and M. tuberculosis, in which ICL is a key enzyme. The GAS
pathway is characterized by flux through the glyoxylate shunt and
also through the carbon fixing anaplerotic reactions at the PEP-
pyruvate-oxaloacetate node (Figure 10). The very high flux
through these ‘anaplerotic reactions’ are in excess of anaplerotic
demands (Table S3) and therefore these reactions are also being
used to oxidize pyruvate generated from glycolysis, in a similar
manner to that described for the novel PEP-glyoxylate cycle in
hungry E. coli [22], and to generate biomass. Another feature of
the novel pathway is a very low flux through the succinate-
oxaloacetate segment of the TCA cycle. Indeed it appears that
most of the flux from the ICL reaction goes, not into the TCA
cycle (to be used for catabolism), but into biosynthesis via succinyl
CoA. Therefore under these conditions ICL plays an anabolic
rather than a catabolic role (in fatty acid dissimilation). Given the
importance of both ICL and PCK in the pathogenesis of the
tubercle bacillus [6,23] the discovery that it operates as part of this
novel metabolic pathway is an important finding that may have
implications for our understanding of how the tubercle bacillus
survives in vivo. The fluxes through this novel pathway were
significantly influenced by growth rate with a shift towards
increased utilization of the glyoxylate shunt at slow growth rate
accompanied by a diversion of precursors from synthesis of acetyl
CoA to synthesis of succinate/succinyl CoA, which is consistent
with our previous data indicating that the shift to slow growth rate
is accompanied by changes in macromolecular composition [1].
Although two functioning ICL enzymes were identified in BCG,
ICL2 has a significantly lower maximum activity [14] and, alone,
may not be able to synthesize sufficient succinate/succinyl CoA for
biosynthetic needs (e.g. synthesis of branched chain fatty acids),
accounting for the observed essentiality of icl1 at slow growth rate.
Indeed icl2 was unable to rescue an icl M. smegmatis mutant for
growth on two carbon substrates or prevent the death of an icl1
mutant of M. tuberculosis during chronic TB infection in mice [5].
The ‘anaplerotic reactions’, PCK/PCA/MEZ, play a key role
in the novel pathway we have described. These reactions may be
used for gluconeogenesis but are also utilized to convert C3 acids
to C4 acids. In E. coli this role is performed by phosphoenolpyr-
uvate carboxylase but this enzyme is absent in M. tuberculosis. At
the slow growth rate we found evidence that this function is
performed primarily by PCK (operating in direction towards
synthesis of oxaloacetate) in BCG and M. tuberculosis, as has been
found for Bacillus subtilis [24]. This is interesting as PCK, like ICL
is required for the growth of M. tuberculosis in macrophages and
mice [23]. PCK catalyses the reversible conversion of oxaloacetate
and phosphophoenolpyruvate and, with PCA and MEZ, controls
the metabolic link between the TCA cycle and glycolysis
represented by the PEP-pyruvate-oxaloacetate anaplerotic node.
Previous data suggested that this enzyme predominantly functions
in the gluconeogenic direction when M. tuberculosis is metabolizing
glucose [23]. Here, we provide evidence that this enzyme can also
operate anaplerotically during slow growth in a glycerol limited
chemostat. Reversable fluxes from PEP to oxaloacetate would
offer M. tuberculosis the metabolic flexibility to fine tune the balance
of catabolic and replenishing reactions. This could be particularly
important in the nutrient restricted human host.
At the fast growth rate, the flux solutions indicated that some
carboxylating anaplerosis was catalysed by either PCA or MEZ.
13C-MFA was unable to distinguish which enzyme was responsible
but we were unable to detect any activity of PCA in vitro. Although
activity of this enzyme has been detected in Mycobacterium smegmatis
[25] PCA activity has never been detected in either BCG or M.
tuberculosis. However, the gene encoding this enzyme was identified
as essential for growth of M. tuberculosis on media containing
glycerol and glucose [26] and therefore we cannot rule out the
possibility that the reaction conditions were not optimum for
assaying this enzyme. The PCA of Corynebacterium glutamicum has
been shown to be very unstable [27] and this may also be the case
for BCG. Malic enzyme decarboxylates malate to pyruvate and is
thought to be important in providing acetate and NADPH for the
biosynthesis of lipids. Although this enzyme can function
anaplerotically, in other bacteria it is generally thought to operate
in the gluconeogenic direction. Low levels of MEZ activity was
detected in the BCG cells but this activity was unaffected by
growth rate. Recent 13C data has provided evidence for malic
enzyme activity in M. tuberculosis [23] whereas early studies had
suggested that activity was very low or absent in slow growing
mycobacteria [17]. Further studies are required to elucidate
precisely which enzymes are involved in these important reactions.
Isotopic tracer experiments using sodium [13C]bicarbonate
confirmed that, in accordance with the flux solutions, an
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appreciable proportion (up to 22% incorporation in some amino
acids after the addition of one volume of media containing sodium
[13C]bicarbonate) of carbon in M. tuberculosis growing in a glycerol
limited chemostat arises from CO2 fixation through carboxylation
reactions. The estimated flux through carboxylating anaplerotic
reactions is much more than the relatively modest requirement for
anaplerotic replenishment of the TCA cycle intermediates due to
their removal for amino acid synthesis (less than 1% of total flux)
and suggests that fixed CO2 is being incorporated into other
components of biomass, as well as amino acids. These data
alongside a number of different studies provide evidence that CO2
fixation maybe important for the growth and virulence of M.
tuberculosis. The stimulatory effect of CO2 on the growth of
mycobacterium has been known for decades [28] and also 14C
tracer experiments performed in the 1950’s demonstrated that M.
tuberculosis could use CO2 as a source of carbon [29,30]. It has also
been shown that physiological relevant levels of CO2 prevent the
growth arrest of M. bovis BCG in a hypoxic model of persistence
[31]. In addition, M. tuberculosis encodes three carbonic anhydras-
es, Rv1284, Rv3273 and Rv3588c which have a role in the growth
and virulence of M. tuberculosis: Rv3588c is essential for growth in
vivo [32] and Rv1284 is essential for in vitro growth [26] and was
also highly upregulated in a starvation model of persistence [33].
These enzymes catalyse the reversible hydration of CO2 to
bicarbonate and are associated with metabolic enzymes such as
PCK, PCA and MEZ which produce or consume CO2 or
bicarbonate.
It is unlikely that M. tuberculosis is operating either the Calvin,
Wood-Ljungdahl or the 3-hydroxypropionate cycles to fix CO2 as
this pathogen does not have a ribulose-bisphosphate carboxylase
(RuBisCO) [34] and the genes for malyl CoA lyase or formate-
tetrahydrofolate ligase are not annotated in the genome [35]. The
presence of KOR and a gene homologous to the ATP-citrate
lyase ß-chain (citE, Rv2498c) has led to suggestions that a
reductive tricarboxylic acid cycle may function to fix CO2 in this
bacterium [34,36]. The flux solutions presented here do indeed
suggest that at least the KOR reaction may operate in the
reductive (carboxylating) direction in some circumstances.
Operation of the entire reductive TCA pathway seems unlikely
as M. tuberculosis lacks the a and c-subunits of citrate lyase
required for the reductive TCA and studies suggest that CitE
functions in fatty acid biosynthesis [37]. The pattern of
incorporation of bicarbonate-derived 13C differed between fast
and slow growth rate, with lysine being the predominant labeled
product at slow growth rate but methionine being the
predominant labeled product at fast growth rate. The carbon
backbone of both amino acids is derived from oxaloacetate
supporting anaplerotic flux via PCK as being the predominant
carboxylating reaction at both growth rates. However, as both
amino acids do share the same four carbon backbone, the shift in
label accumulation between lysine and methionine at slow and
fast growth rate is puzzling. One possibility is that the difference
is due to differences in the degree of labeling of the methyl group
of methionine, which is not derived from oxaloacetate but via a
methylation reaction performed by methionine synthase with
methylated tetrahydrofolate being the C1 source. The ultimate
source of the carbon atom in C1 metabolism of mycobacteria has
however not been determined.
Conclusions
This study is the first to use 13C-MFA to investigate the
metabolism of a mycobacterium. Using this method we identify a
novel metabolic pathway operating in M. tuberculosis which we
have named the GAS pathway (Figure 8) because it utilizes the
glyoxylate shunt and anaplerotic reactions for oxidation of
pyruvate combined with very low flux through the succinate –
oxaloacetate segment of the TCA cycle. These results also add to a
growing body of evidence which indicates that ICL is involved in
processes beyond lipid metabolism in vitro, and probably also in
vivo. We demonstrate that the fluxes through this novel pathway
are influenced by growth rate such that one of the two ICL’s
becomes essential at slow growth rate. This essentiality is unrelated
to lipid catabolism and appears to reflect an anabolic shift at slow
growth rate, possibly towards synthesis of complex lipids. The
relevance of these findings to the in vivo situation is demonstrated
by our previous finding that adaptation M. tuberculosis to growth in
macrophages also involves a shift to slow growth. The GAS
pathway is also characterized by significant levels of CO2 fixation
through anaplerotic reactions that generate oxaloacetate. We were
able to confirm significant levels of CO2 fixation in M. tuberculosis.
Given the importance of the glyoxylate shunt in the pathogenesis
of the tubercule bacillus and the abundance of CO2 in the human
host, the discovery of this novel pathway is an important finding
that is likely to be relevant to the pathogenesis of tuberculosis.
Materials and Methods
Bacterial strains and growth conditions
M. bovis BCG strain (ATCC 35748) or Mycobacterium tuberculosis
(H37Rv) was cultured in a 2- l bioreactor (Adaptive Biosystem
Voyager) under aerobic conditions and at pH 6.6 as previously
described [1]. Chemostat cultures were grown in Roisin’s minimal
medium at a constant dilution rate of 0.03 h21 (equivalent to a
doubling time, td of 23 h) or 0.01 h
21 (td = 69 h). Culture samples
were withdrawn from the chemostat to monitor cellular dry
weight, viable counts, optical density, nutrient utilization and CO2
and O2 levels were measured in the exhaust gas [1]. After waiting
five residence times at a particular dilution rate, the reactor was
assumed to be at steady state if the OD, glycerol concentration,
oxygen uptake rate and CO2 production rate were steady within a
15% range for 48 h. Once the steady state was reached cells were
harvested for analysis.
The 13C labeling experiments were initiated after the chemostat
culture was in steady state by replacing the feed medium with an
identical medium containing a mixture of 1 ml [13C3]glycerol and
4 ml of natural glycerol l21. For the carbon fixation chemostat
experiments a modified Roisin’s medium was used which
contained 0.15% sodium bicarbonate [38]. After steady state
was achieved the medium was replaced with an identical medium
containing 0.15% sodium [13C]bicarbonate. Since CO2 is rapidly
lost to air from a stirred solution of sodium bicarbonate, the
chemostat air supply was made recyclable by connecting the
effluent gas outlet to the air inlet. Oxygen concentrations were
monitored carefully to ensure that oxygen levels remained above
70%. Biomass samples for GC-MS analysis were taken for analysis
every volume change.
Culture analysis
Biomass and supernatant samples were collected and harvested
[1]. Biomass was determined according to the method described
by Lynch and Bushell [39]. The amounts of glycerol in the
supernatant and in fresh medium were assayed by use of a
commercial assay kit that employs a glycerokinase-coupled
enzyme assay system (Boehringer Mannheim). To assay for
Tween 80 supernatant samples were hydrolysed by boiling for
1 h in methanolic KOH (5% potassium hydroxide: 50%
methanol). After neutralizing the samples with HCl the free fatty
acids were assayed using a commercial kit (Roche). Non-
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hydrolysed samples were also analyzed to measure any free fatty
acids present in the supernatant.
Macromolecular composition
The macromolecular composition of the cellular biomass was
determined from freeze-dried cell pellets as previously described [1].
Strain construction
For the construction of an isocitrate lyase mutant, E. coli strain
DH5a was grown in solid or liquid Luria-Bertani (LB) medium as
described by Sambrook et al. [40]. M. bovis BCG cells were
propagated in Middlebrook 7H9 broth or 7H11 agar containing
5% (v/v) OADC enrichment media supplement (Becton Dick-
enson), 0.5% glycerol plus 0.05% Tween 80 for liquid cultures.
For mycobacteria, when selection was required, kanamycin at
20 mg ml21, X-gal at 50 mg ml21 and sucrose at 2% (w/v) were
added to the culture media.
An unmarked isocitrate lyase mutant of M. bovis BCG was
constructed using the strategy described by Parish and Stoker [41].
PCR was used to amplify two separate 1 kb DNA regions flanking
the M. bovis BCG icl1 gene. These fragments were cloned into
p2NIL to generate p2NIL-icl1. The final delivery vector was
generated by cloning the Pac I cassette from pGOAL19 into the
p2NIL-icl1 construct to give pUSicl1. Single crossovers were
selected for on 7H11 agar supplemented with kanamycin and X-
gal and then grown in media lacking antibiotics to allow the
second recombination to occur. Following growth the cells were
sub-cultured onto sucrose plates to select for sucrose-resistant
white colonies, which had lost the integrated plasmid through a
second crossover. PCR and Southern analysis were performed to
verify the expected genotypes.
Analysis of in vitro enzyme activities
Crude enzyme extracts were prepared according to Tian et al
(2005) with minor modifications [2]. Protein was assayed using the
Bio-Rad DC protein assay kit and following the manufacturer’s
instructions. All reaction mixtures (1 ml) contained 100 mg of M.
bovis BCG lysates.
Isocitrate dehydrogenase (ICDH). ICDH was assayed as
described [19].
Phosphoenolpyruvate carboxykinase (PCK). The pro-
cedure described by Mukhopadhyay et al (2001) was used for
assaying PCK activity in the direction of oxaloacetate formation [42].
Malic enzyme (malate dehydogenase, decarboxylating)
(MEZ). A modification of previously described procedures was
used to assay for MEZ activity [17,43,44]. The reaction mixture
contained 100 mM Tris-HCl (pH 7.8), 5 mM MnCl2, 40 mM
sodium L-malate, 0.6 mM NADP+, 20 mM KCl. Reactions were
monitored spectrophotometrically by following the production of
NADPH at 340 nm (e=6.223 M21 cm21) at 30uC.
Pyruvate carboxylase (PCA). PCA was assayed exactly as
described [25].
Glycine dehydrogenase (GDH). GDH was monitored by
the method described by Wayne (1996) [45].
Construction of an isotopomer model of central
metabolism in M. tuberculosis
An isotopomer model of central metabolism (Figure 3, Table
S1) in M. tuberculosis and M. bovis BCG was constructed in the
framework of 13CFLUX [18] (http://www.13cflux.net/), a soft-
ware toolbox for flux distribution estimation.
The model was based on our GSMN-TB genome-scale model
[2] of M. tuberculosis and includes reactions of glycolysis (EMP), the
pentose phosphate pathway (PPP), the tricarboxylic acid cycle
(TCA) and anaplerosis (ANA). Moreover, all biosynthesis path-
ways relevant for M. tuberculosis are formulated in simplified form
in that linear reaction sequences are combined into one reaction
(Figure S1). The scrambling reaction tca6a/b is assumed to
proceed in equal proportion. This metabolic network model was
supplemented with carbon atom transitions and consisted of a total
of 75 reactions. Flux values for net and exchange rates can be
derived from 47 independent flux parameters (35 net +12
exchange) that are estimated using 137 labeling measurements
(mass isotopomers of amino acids, Table S3) and 30 flux
measurements obtained from biomass hydrolysates or calculated
from intermediates (25 precursor requirements, (Table S4),
(labeled) glycerol and Tween 80 uptake rates (Table 1) as well as
the overall CO2 net production rate.
In order to incorporate enzyme activities, steady state data for
experiments with different growth rates mS=0.01 h21 and
mF=0.03 h21 are fitted in one model. This is achieved by
doubling all reaction equations of the basic flux model (Figure S1).
The two sub-models are then ‘‘loosely’’ connected via inequality
constraints reflecting the tendencies of measured activities between
slow and fast growth for the enzymes PCK, ICL and ICDH (see
also results).
Biomass hydrolysate and preparation of amino acid
derivatives
Biomass samples from the 13C labeled chemostat cultures were
washed and hydrolysed as described by Borodina et al, 2008 [46].
The dried hydrosylate was dissolved in 1 ml norvaline solution
(0.075 mM in 80:20 H2O:MeOH). 0.1 ml was dried in-vacuo and
this mixture was derivatised by adding 140 ml acetonitrile:N-tert-
butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA):1%
tert-butyldimethylchlorosilane (TBDMCSI), 1:1., sonicating (room
temperature, 30 min) and then heating (90uC, 30 min) to
complete the derivatisation. Samples were analysed by Gas
Chromatography-Mass Spectrometry (GC-MS) within 72 h after
derivitisation. The concentration of protein in each hydrolysate
was determined using the Lowry method [47]. Bovine serum
albumin was used as a standard and was included with each set of
samples.
GC-MS analysis
The analysis was performed with a 6890N Network GC system
(Agilent) fitted with a DB-5ms capillary column (15 m60.18 mm
internal diameter60.18 mm film with 5 m Duraguard integrated
guard column) and deactivated quartz wool packed FocusLiner
(SGE) coupled to a Pegasus III time-of-flight (TOF) mass
spectrometer (Leco) equipped with a splitless injector. The injector
temperature was initially held at 70uC for 2 min followed by
heating to 350uC at a rate of 17uC min21. This temperature was
held for 1.5 min. The flow was held constant at 1.4 ml He min21.
Injection volume, 5 ml. Inlet temperature, 250uC. Interface
temperature, 310uC. Source temperature, 245uC. The system
was operated with a mass range of 40–800 m/z at an EM voltage
of 70 V with a spectral acquisition rate of 20 spectra s21.
13C isotopologue abundances (i.e., 13C incorporation; 12Cn,
13C1, …, 13Cn) for each amino acid were determined for
fragments containing the intact carbon skeleton for each amino
acid; generally using the [M-57]+ ion. To obtain further
information relating to the 13C incorporation at individual
positions within individual amino acids, isotopologue abundances
were also determined for fragments formed by cleavage of the C1–
C2 bond in some samples. Within a subset of these, isotopologue
abundances for the fragment formed by cleavage of the C2–C3
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bond in serine were also determined allowing comprehensive
characterization of the isotopic incorporation into serine. Mass
spectra of the derivatized amino acids were corrected for the
natural abundance of all stable isotopes.
Flux parameter estimation
Non-linear weighted least squares fitting is applied in order to
determine the flux values which are the most likely description of
the labeling data and biomass constraints [48]. Initial flux
distributions are generated by Monte Carlo sampling and used
for a multi-start optimization. For validation of the solution, flux or
labeling measurements (whole groups, C2-Cn fragments or single
measurements) that fit the least are combinatorially removed from
the data set. Solutions obtained using the reduced data set that are
consistent with the best fit gives an indication that the estimated
flux values describe the experimental data set.
Statistical analysis
Based on normally distributed measurement errors, flux errors
were calculated using a linearized statistical approach [48].
Phosphoglucose isomerise (PGI) and PCK were constrained to
fitted values in order to determine confidence levels for the split
ratio between glycolysis and the pentose phosphate pathway as
well as the reaction cycle consisting of PCK, PCA/MEZ, pyruvate
kinase (PK). These fluxes are comparably low and and so this was
not a severe restriction. As is common practice all net fluxes in
direction of biomass synthesis are likewise constrained. Resulting
flux standard deviations are given in Table S4.
Supporting Information
Figure S1 Southern analysis of the icl1 mutant. Chro-
mosomal DNA isolated from WT M. bovis BCG (lane 2) and Dicl
(lane 3) were digested with BglII and transferred to a nylon
membrane. The membrane was probed with the digoxigenin
labeled probe HR containing the icl1 gene and its flanking regions.
The WT fragments are the expected 3.99 kb and 1.9 kb fragments
while the genomic DNA from the Dicl had the expected 2.62 kb
fragment. The sizes of the bands were determined from the
migration distance of the DNA molecular mass marker EcoRI
SPP1 (Roche ladder number VII) which is present in lane 1.
(TIF)
Table S1 Non stationary and stationary 13C isotopomer
abundance of amino acids from protein hydrolysis.
Incorporation of 13C label into the protein amino acids of M. bovis
BCG cells grown in a chemostat at a dilution rate of 0.01 h21 with
20% [13C3]glycerol.
(XLS)
Table S2 Network model of the central metabolism of
Mycobacterium bovis BCG and Mycobacterium tubercu-
losis. Stoichiometry and carbon transformations for reactions in
the network of M. bovis BCG and M. tuberculosis. This network
consists of 75 reactions.
(DOC)
Table S3 Experimentally derived requirements and
estimated effluxes from intermediate and amino acid
pools for biomass synthesis of Mycobacterium bovis
BCG (BCG) and Mycobacterium tuberculosis (MTB)
growing in a chemostat. The precursor requirements for
amino acid pools were derived from measurements of the
macromolecular composition of biomass hydrolysates.
(XLS)
Table S4 Experimental (GC-MS) and calculated mass
distributions in the amino acid derivatives of Mycobac-
terium bovis BCG (BCG) and Mycobacterium tubercu-
losis (MTB) growing in a steady state chemostat. GC-MS
measured values for the 13C incorporation into proteogenic amino
acids as compared with the values calculated using 13CFLUX.
(XLS)
Table S5 Estimated metabolic fluxes of Mycobacterium
bovis BCG (BCG) and Mycobacterium tuberculosis
(MTB). In vivo fluxes for glycerol limited M. bovis BCG and M.
tuberculosis growing at either fast (td = 23 h) or a slow (td = 69 h)
growth rate in a chemostat.
(XLS)
Table S6 Abbreviations of metabolite names. Explicit
names of enzymes and metabolites used in this work.
(DOC)
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